Purchase Order 75N96022P00267

This is a firm fixed-price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian federal agency, to Twinstrand Biosciences Inc., a for-profit company based in Seattle, Washington. The $24,000.00 contract is for the provision of a SEQUENCING UNIVERSAL KIT. The award date was August 26, 2021, with a completion date of September 30, 2021. The contract has no set-aside designation. Twinstrand Biosciences Inc. has a history of securing federal contracts...

This is a $49,987.65 firm fixed price purchase order awarded by the Food and Drug Administration (FDA) to Twinstrand Biosciences Inc. for a Twinstrand Duplex Sequencing Mutagenesis Kit. The contract has an ultimate completion date of September 25, 2024. Twinstrand Biosciences Inc. is a for-profit company that provides DNA sequencing services and products. They have previously supported the FDA and National Institute of Environmental Health Sciences through federal contracts and grants, including...

This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...

This is a firm fixed price purchase order contract awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a for-profit synthetic biology company based in South San Francisco, California. The contract is for the provision of biological and reagent materials, with a ceiling value of $12,206.25 and a period of performance through September 4, 2025. There is no set-aside designation for this...

Twist Bioscience Corporation has been awarded a firm fixed price purchase order contract valued at $24,285 by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide a custom single site variant library. As the prime contractor, Twist Bioscience will deliver the requested synthetic DNA products to support genomics research efforts. No set aside designation was applied to this award. Twist Bioscience is a manufacturer of synthetic DNA based in...

This firm fixed price purchase order for $19,980.00 was awarded by the National Human Genome Research Institute, a civilian federal agency, to Pacific Biosciences of California, Inc. on December 2, 2020. The award is for the delivery of SMRT CELL 8M TRAYS, with a completion date of January 1, 2021. The contract does not have a set-aside designation. Pacific Biosciences is the original equipment manufacturer of the Sequel and Sequel II DNA/RNA sequencing systems. The company has been awarded over...

This is a firm fixed-price BPA call contract awarded by the U.S. Army Criminal Investigation Command to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract, valued at $92,180.20, is for the procurement of PN4427368 IDENTIFILIER PLUS (CLIN 0018) and has an ultimate completion date of April 27, 2016. The contract has no set-aside designation. As a division of Thermo Fisher Scientific, Life Technologies has provided specialized...

This is a firm fixed price contract awarded by the Plains Area division of a civilian federal agency to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract, valued at $148,081.20, is for the provision of TruSeq Stranded mRNA LT-Set A (219) products. There is no set-aside designation for this award. Illumina has previously provided sequencing systems, reagents, and services to support genomic research and diagnostics across various government...

This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a firm fixed price purchase order valued at $15,117.00 to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the delivery of a TWIST Library Preparation Kit 1. This award does not have a set-aside designation. Twist Bioscience is a prime contractor on this purchase order, which has an ultimate completion date of October 14, 2024. The company...